Induction of platelet refractoriness after myeloablative unrelated allogeneic hematopoietic peripheral blood progenitor cell transplant from HLA-sensitized female donor
Fabiana M. Conti MD, MSc
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorAndrea T. Kondo MD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorCarolina Bub MD, MSc
HLA Laboratory, Department of Medical Diagnostics, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorMargareth Torres MD, MSc
HLA Laboratory, Department of Medical Diagnostics, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorRicardo Helman MD, MSc
Department of Hematology, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorMariza Mota MD, PhD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorAraci Sakashita MD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorJose M. Kutner MD, PhD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorNelson Hamerschlak MD, PhD
Department of Hematology, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorFabiana M. Conti MD, MSc
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorAndrea T. Kondo MD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorCarolina Bub MD, MSc
HLA Laboratory, Department of Medical Diagnostics, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorMargareth Torres MD, MSc
HLA Laboratory, Department of Medical Diagnostics, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorRicardo Helman MD, MSc
Department of Hematology, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorMariza Mota MD, PhD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorAraci Sakashita MD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorJose M. Kutner MD, PhD
Department of Hemotherapy and Cell Therapy, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this authorNelson Hamerschlak MD, PhD
Department of Hematology, Hospital Albert Einstein, Sao Paulo, Brazil
Search for more papers by this author
References
- 1Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol 2008; 142: 348-360.
- 2Taniguchi K, Yoshihara S, Maruya E, et al. Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors. Bone Marrow Transplant 2012; 47: 1338-1342.
- 3Yoshihara S, Taniguchi K, Ogawa H, et al. The role of HLA antibodies in allogeneic SCT: is the “type-and-screen” strategy necessary not only for blood type but also for HLA? Bone Marrow Transplant 2012; 47: 1499-1506.
- 4Nakazawa Y, Saito S, Hasegawa Y, et al. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. Transfusion 2007; 47: 326-334.
- 5Uchiyama Y, Hoshino T, Mihara M, et al. Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia. Rinsho Ketsueki 2013; 54: 214-218.
- 6Balduini CL, Salvaneschi L, Klersy C, et al. Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. Leukemia 2001; 15: 1885-1891.
Citing Literature
